• Company
• Insurance benefit for Vemlidy expanded in Korea
• by May 4, 2022 06:03am

• Opinion
• [Reporter’s View] Use of maintenance and adjuvant therapies
• by Eo, Yun-Ho May 4, 2022 06:03am

• Company
• Boryung challenges patent for leukemia drug Tasigna
• by Kim, Jin-Gu May 4, 2022 06:03am

• Company
• The first oral GLP-1 Novonodisc's Rybelsus was approved
• by May 4, 2022 06:03am

• Company
• When will the discussion on Dupixent's benefit be concluded?
• by Eo, Yun-Ho May 3, 2022 06:09am

• Company
• Cephalosporin CMOs discontinue or downsize business
• by Kim, Jin-Gu May 3, 2022 06:09am

• Company
• GSK Consumer Healthcare Korea appoints Dongwoo Shin as CEO
• by May 3, 2022 06:09am

• Company
• COVID-19 vaccine SKYCovione has been applied
• by Kim, Jin-Gu May 3, 2022 06:08am

• Company
• Generics for Xarelto with sales of ₩60 billion are com
• by Kim, Jin-Gu May 3, 2022 06:08am

• Company
• Nerlynx reattempts at reimb after failing CDDC review
• by Eo, Yun-Ho May 2, 2022 06:03am